76N-052N OTC Nasal Decongestants
MT 11 HFD-560 & Bayer Corporation Vol#: 77
98P-0418 Olestra & other Partially or Totally Nondigestible Fats
00P-0499 Review/Act on SKB '132 Form C & '423 Form A patent for NDA20
C 7 GlaxoSmithKline Corporation Vol#: 2
01D-0584 Reduce the Risk of Transmission of HIV-1 & HCV
01N-0231 Veterinary adverse drug reaction, lack of effect, product
NAL 1 Vol#: 1
SS 1 Supporting Statement Vol#: 1
01N-0339 Medical Washer & Medical Washer-Disinfector
EC 1 Bloomington Hospital Vol#: 1
EC 2 Sutter Tracy Community Hospital Vol#: 1
01N-0437 New Animal Drugs for Investigational;Agency Information Coll
NAL 1 Vol#: 1
SS 1 Supporting Statement Vol#: 1
01P-0230 Domestic Marketing & Importation of Transgenic Fish
C 879 Elizabeth Hamilton Vol#: 190
C 880 Elizabeth Hamilton Vol#: 190
C 881 Elizabeth Hamilton Vol#: 190
C 882 Geoff Bell-Devaney Vol#: 190
01P-0248 Clarify Issues Relating to Patent Listings in "Orange Book"
C 4 GlaxoSmithKline Corporation Vol#: 1
01P-0574 Referencing discontinued labeling for Octreotide acetate inj
RC 2 Novartis Pharmaceuticals Corporation Vol#: 1
01V-0424 Laser Light Show
VRA 1 HFZ-300 to Chilewig Vol#: 1
01V-0433
VRA 1 HFZ-300 to General Theatrical Supply Vol#: 1
01V-0588 Variance for Q-Beam series % Oracle - Tube, Hex1 & Hex2, (01
VRA 1 HFZ-300 to Cinemark Imax Vol#: 1
02D-0002 Inhaltional Anthrax (Post-Exposure) - Developing Antimicrobi
C 1 Bristol-Myers Squibb Vol#: 1
02D-0096 Nucleic Acid Tests on Samples from Blood Donors to Reduce Ri
02M-0180 Model AC21B UV-Absorb'g PMMA Anterior Chamber Intraocular Le
AAV 1 Ophthalmic Innovations, International In Vol#: 1
02N-0054 Labeling Requirements for Color Additives
EC 3 Ms. Whitney Hull Vol#: 1
02N-0102 Notification of a health claim based Authoritative Statement
EC 2 Mr. Jeffrey Mason Vol#: 1
02N-0112 Regulations Under the Federal Import Milk Act
EC 1 Ms. Lina Maria Moyano Vol#: 1
02N-0115 Risk Management of Prescription Drugs; Public Hearing
EC 2 Mrs. Ronald Bryson Vol#: 1
02N-0123 Food Canning Establishment Registration, Process Filling
N 1 Vol#: 1
02N-0152 Obtain Timely Pediatric Studies & Adequate Pediatric Labelin
EC 1 Number Not Used Vol#: 1
EC 2 Number Not Used Vol#: 1
02P-0170 ANDAs relaying Premax as reference listed drug not be appove
C 1 The Weinberg Group, Inc. Vol#: 1
02P-0205 SRNT petition to regulate Ariva tobacco lozenges
CP 1 Society Research on Nicotine and Tobacc Vol#: 1
02P-0206 SRNT to regulate Omni and Adance cigarettes
CP 1 Society Research Nicotine and Tobacco Vol#: 1
02P-0207 SRNT petition to regulate SF Garrett's Nicotine Water
CP 1 Society Research Nicotine and Tobacco Vol#: 1
02V-0041 Laser Light Show
VRA 1 HFZ-300 to Laser Wizardry East Vol#: 1
02V-0090
VRA 1 HFZ-300 to Powerhouse Productions Vol#: 1
02V-0092
VRA 1 HFZ-300 to Poseidon, Inc. dba Mythos Vol#: 1
02V-0111
VRA 1 HFZ-300 to Mixed Entertainment Corp. Vol#: 1
02V-0117
VRA 1 HFZ-300 to Intense Lasers, Inc. Vol#: 1
02V-0126
VRA 1 HFZ-300 to Dynamic Sound Lighting & Musi Vol#: 1
02V-0201
ACK 1 HFA-305 Vol#: 1
VAR 1 AV-Pro Inc. Vol#: 1
02V-0202 Laser Light Show and Projector
ACK 1 HFA-305 Vol#: 1
VAR 1 Digital Jamz Vol#: 1